Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (401-410 of 404) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 404 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 4, 2024
Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infectionAye Mya Sithu Shein, Dhammika Leshan Wannigama, Cameron Hurst, et al.
Iscience|July 27, 2023
Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing <i>Klebsiella</i><i>pneumoniae</i> infectionsDhammika Leshan Wannigama, Aye Mya Sithu Shein, Cameron Hurst, et al.
Iscience|February 20, 2024
Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmissionSuparinthon Anupong, Sudarat Chadsuthi, Parichart Hongsing, et al.
Scientific Reports|November 23, 2024
Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniaeAye Mya Sithu Shein, Dhammika Leshan Wannigama, Cameron Hurst, et al.
Pageof 41

Showing results (401-410 of 404) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 404 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 4, 2024
Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infectionAye Mya Sithu Shein, Dhammika Leshan Wannigama, Cameron Hurst, et al.
Iscience|July 27, 2023
Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing <i>Klebsiella</i><i>pneumoniae</i> infectionsDhammika Leshan Wannigama, Aye Mya Sithu Shein, Cameron Hurst, et al.
Iscience|February 20, 2024
Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmissionSuparinthon Anupong, Sudarat Chadsuthi, Parichart Hongsing, et al.
Scientific Reports|November 23, 2024
Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniaeAye Mya Sithu Shein, Dhammika Leshan Wannigama, Cameron Hurst, et al.
Pageof 41